Want to join the conversation?
$MDXG said it agreed to buy Stability Biologics, provider of human tissue products. $MDXG sees deal to be accretive to Adjusted EPS in 2016, and sees 2016 Stability Biologics revenues generated from processed tissue and bone product sales and distribution to be at least $15MM. The deal is expected to close by mid-Jan.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.